申请人:Langham John Barry
公开号:US20070099894A1
公开(公告)日:2007-05-03
A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 2-position by a carbonyl- or sulfonyl-linked pyrrolidin-1-yl or related moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.
一系列的thieno[2,3-b]pyridin-6(7H)-one衍生物,在2位被一个羰基或磺酰基连接的吡咯烷-1-基或相关的基团取代,是p38 MAP激酶的抑制剂,因此在医学上具有用途,例如在治疗和/或预防免疫或炎症性疾病方面。